Reed Smith Client Alerts

On January 15, 2020, the U.S. House of Representatives, Subcommittee on Energy and Commerce held a hearing on "Cannabis Policies for the New Decade." Although the hearing was intended to facilitate discussion on six proposed cannabis bills, it turned into a discussion centered on one major issue - the scarce availability of sound research results regarding the use of marijuana and its deleterious effect on the evolution of marijuana policy in the United States.

Authors: Claudia Z. Springer Adam D. Brownrout

On January 15, 2020, the U.S. House of Representatives, Subcommittee on Energy and Commerce held a legislative hearing on “Cannabis Policies for the New Decade,” the first-ever cannabis hearing for this particular legislative committee. The following people were in attendance to answer questions and provide testimony on cannabis policy:

  1. Nora Volkow, director of the National Institute of Drug Abuse;
  2. Matthew Strait, a senior policy advisor with the Drug Enforcement Administration; and
  3. Douglas Throckmorton, deputy director of regulatory programs at the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research.